Clinical Trials Browser

Phase 2 × INDUSTRY × Hormone Refractory Prostate Cancer × Clear all

NCT00667199 2023-04-19

BAY88-8223, Does Response Study in HRPC Patients

Phase 2 Completed

Hormone Refractory Prostate Cancer

NCT00525408 2012-03-12

HRPC

Phase 2 Terminated

Hormone Refractory Prostate Cancer

NCT01215799 2011-12-15

PROACT

Phase 2 Completed

Hormone Refractory Prostate Cancer